News On Projects
Products & Services
Projects Database
Tenders Database
E - Newsletter
EPXonline.com
Project Financing
Contracts & Awards
Energy
Electricity
Mining
Oil & Gas
Infrastructure
Airport
Port
Railway
Road
Freezone
Construction
Manufacturing
Cement
Engineering
Automobile
Plastic
Metal
Textile
Paper & Packaging
Leather
Sugar
Edible Oil
Electrical & Electro
Processing
Chemical
Drugs & Pharma
Fertiliser
I-C-T
Communication
IT
Telecom
Water
Pump Station
Water Treatment
Water Supply
Hospitality
Hotel
Restaurant
Resort
Entertainment
Sports
Multiplex
Theme Park
Food & Beverages
Hospital
Service
Social
Science
Irrigation
Government
Policy
Economic Indicators
Company News
Commerce
Miscellaneous
News Uploaded On : Saturday, April 23, 2016 2:57:00 PM IND Back  |  Latest Projects  |  Latest Tenders
 
 E-mail this to a friend        Printable version       Story Viewed 1234 Times
Alembic Pharma forms JV with Orbicular for derma products.
Alembic Pharmaceuticals Ltd (APL) has formed a 60:40 joint venture (JV) with the Hyderabad-based Orbicular Pharmaceutical Technologies Pvt Ltd to develop & commercialise dermatology products for global markets.

“Alembic Pharmaceuticals has entered into joint venture agreement with Orbicular Pharmaceutical Technologies Private Limited (Orbicular) and Dr M S Mohan to develop, manufacture and commercialise dermatology products for global markets,” said APL in a press release.

Orbicular has capabilities in developing dermatology products with a fully-equipped and staffed research laboratory in Hyderabad and has a pipeline of products under various stages of development. Manufacturing facility will be established in Aleor Dermaceuticals to enable worldwide registrations, it added.

Orbicular business model revolves around building a product portfolio of niche generic and specialty pharmaceutical products and its licensure at mid or late stage. Orbicular focuses on broad range of innovative, differentiated and complex products mainly in niche dosage domains like injectables, ophthalmics, otics, oral dosages and topical products.

BS

Post your comments:

Your name: *
E-Mail Id:
E-mail ID will not be published
Comment: *
Maximum 500 Characters
    
Related Stories
China’s Fosun bids to buy India’s Gland Pharma.
Rusan Pharma aims to double turnover to Rs 600 cr by 2018
Indoco Remedies shares soar 19% on USFDA nod for Goa plant.
GSK Pharma plans Rs. 500-cr expansion of its Nashik unit.
Mankind Pharma to invest Rs. 150 crore in Paonta Sahib plant.
Green panel okays Aurobindo Pharma's Telangana unit expansion.
GSK begins work on new factory to make tablets and capsules.
IICT promises to assist pharma industry in AP.
IDPL modernises tablet making unit at Gurgaon plant.
Aurobindo Pharma to build three formulation plants in Andhra Pradesh, Telangana.
RELATED PROJECTS & TENDERS
ADVERTISEMENT
MOST POPULAR STORIES NOW
For all enquiries please contact
Tel: 022 - 25961254, 25960909
Mobile: 9821464666/09751178830
Mail: marketing@newsonprojects.com

OUR OTHER PRODUCTS & SERVICES:    Projects Database   |   Project e-Newsletter   |   Tenders Database   |   Commissioned Power Plants   |   Company Index
About Us   |   Contact Us   |   Terms of Use   |   Advertise with Us   |   Privacy Policy   |   Disclaimer   |   Feedback